On June 30, 2024, the Board of Directors (the “Board”) of Merus N.V. (the “Company”) appointed Fabian Zohren, M.D., Ph.D. to serve as the Company’s Chief Medical Officer, effective as of July 1, 2024
Departed
Andrew Joe
Chief Medical Officer
Merus N.V.
Effective
2024-07-01
Successor
Fabian Zohren
Filed
July 1, 2024, 7:59 PM ET
succeeding Andrew Joe, M.D. in such role
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Fabian Zohren was appointed as Chief Medical Officer at Merus N.V..
Action
appointed
Role
Chief Medical Officer
Exact text from the filing
On June 30, 2024, the Board of Directors (the “Board”) of Merus N.V. (the “Company”) appointed Fabian Zohren, M.D., Ph.D. to serve as the Company’s Chief Medical Officer, effective as of July 1, 2024
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.